Most-used long-read sequencers ranked by how many preprints say they used each

Long-read sequencers read single DNA or RNA molecules thousands of bases long, often far longer. That's enough to span the repeats and rearrangements that short reads miss. Updated daily (as of Nov 16)

Nanopore PromethION is the most-used long-read sequencer.

Nanopore PromethION had 40% of the uses in Jun–Nov 2026, up from 39% the year before. Nanopore MinION is second with 33%.

#PlatformLast 6 monthsGrowthTotalBy year
1 PromethIONOxford Nanopore 285 preprints +18% 887 39%
2 MinIONOxford Nanopore 241 preprints −5% 844 37%
3 RevioPacBio 195 preprints +53% 535 24%

Last 6 months is Jun–Nov 2026. Growth compares it with Jun–Nov 2025, as a share of all preprints. Total counts every preprint since April 2025 that says it used the platform.

Top institutions for each platform

  1. Stanford University16
  2. University of Washington14
  3. Australian National University9
  4. University of Copenhagen9
  5. Norwegian University of Life Sciences9
  1. University of Washington12
  2. University of Pittsburgh10
  3. Imperial College London7
  4. Uppsala University7
  5. Academia Sinica6
  1. University of Washington15
  2. Arizona State University9
  3. University of California, Davis7
  4. Stanford University7
  5. University of California, Berkeley6

Counts every preprint since April 2025, by the corresponding author's institution.

PacBio Revio is growing fastest.

Up 53% in Jun–Nov 2026 vs the previous year as a share of all preprints. Nanopore PromethION was up 18% and Nanopore MinION down 5%. All three together grew 16%. Compare side by side: Revio vs PromethION →

PromethIONMinIONRevio

Latest preprints using long-read sequencing

How we count which preprints use each platform

An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.

Want to reach out to the labs using each product?

Get the PIs behind the preprints: institutions, labs, platforms they used, and how to reach them.

Institutions with the most preprints using these platforms